Related references
Note: Only part of the references are listed.Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China
Terry Cheuk-Fung Yip et al.
GASTROENTEROLOGY (2020)
Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naive patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis
Sung Won Lee et al.
GUT (2020)
Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS)
Danae Bixler et al.
CLINICAL INFECTIOUS DISEASES (2019)
Effect of treatment of hepatitis B patients with tenofovir disoproxil or entecavir on risk of hepatocellular cancer death in a US Cohort
Stuart C. Gordon et al.
JOURNAL OF HEPATOLOGY (2019)
A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in South Korea
Seung Up Kim et al.
JOURNAL OF HEPATOLOGY (2019)
Notice of Retraction and Replacement. Choi et al. Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B: a Korean nationwide cohort study. JAMA Oncol. 2019;5(1):30-36
Young-Suk Lim et al.
JAMA ONCOLOGY (2019)
Residual risk of HCC during long-term oral nucleos(t)ide analogues (NUCs) in patients with CHB - Is one NUC better than the other?
Grace Lai-Hung Wong et al.
JOURNAL OF HEPATOLOGY (2019)
Tenofovir vs Entecavir for Hepatocellular Carcinoma Prevention in Patients With Chronic Hepatitis B One of These Things Is Not Like the Other
Jennifer A. Flemming et al.
JAMA ONCOLOGY (2019)
Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B A Korean Nationwide Cohort Study
Jonggi Choi et al.
JAMA ONCOLOGY (2019)
Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection
Kazumoto Murata et al.
GUT (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2018)
Mortality, liver transplantation and hepatic complications in patients with treatment-naive chronic hepatitis B treated with entecavir vs tenofovir
Byung Gyu Kim et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Effectiveness of hepatitis C antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma
Lauren A. Beste et al.
JOURNAL OF HEPATOLOGY (2017)
Long-term use of oral nucleos(t)ide analogues for chronic hepatitis B does not increase cancer risk - a cohort study of 44 494 subjects
G. L. -H. Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
AASLD guidelines for treatment of chronic hepatitis B
Norah A. Terrault et al.
HEPATOLOGY (2016)
Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis
Anna S. F. Lok et al.
HEPATOLOGY (2016)
Care Delivery and Outcomes Among US Veterans With Hepatitis B: A National Cohort Study
Marina Serper et al.
HEPATOLOGY (2016)
Risk of Hepatocellular Carcinoma After Sustained Virological Response in Veterans With Hepatitis C Virus Infection
Hashem B. El-Serag et al.
HEPATOLOGY (2016)
Epidemiology and outcomes of hepatitis C infection in elderly US Veterans
H. B. El-Serag et al.
JOURNAL OF VIRAL HEPATITIS (2016)
The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis
Donna L. White et al.
GASTROENTEROLOGY (2015)
Trends in Burden of Cirrhosis and Hepatocellular Carcinoma by Underlying Liver Disease in US Veterans, 2001-2013
Lauren A. Beste et al.
GASTROENTEROLOGY (2015)
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2015)
Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA
L. Gao et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B
A. K. Singal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Utilization of Surveillance for Hepatocellular Carcinoma Among Hepatitis C Virus-Infected Veterans in the United States
Jessica A. Davila et al.
ANNALS OF INTERNAL MEDICINE (2011)
Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
Fasiha Kanwal et al.
GASTROENTEROLOGY (2011)
Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis
George N. Ioannou et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in US. Veterans with hepatitis C
JR Kramer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Share Paper
